Truncated forms of DNA-binding estrogen receptors in human breast cancer.

The likelihood a breast cancer will respond to antiestrogen therapy depends on the tumor content of immunoreactive or ligand-binding estrogen receptor (ER). To investigate the failure of many ER-positive breast cancers to respond to antiestrogen therapy, we examined by gel-shift assay the ability of...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Scott, G K, Kushner, P, Vigne, J L, Benz, C C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1991
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295419/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1864980/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115356
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!